Pharmacovigilance & Safety Services: Safeguarding Patient Outcomes in Drug Development
In the high-stakes arena of pharmaceutical advancement, pharmacovigilance (PV) and safety monitoring are essential for identifying, assessing, and mitigating risks associated with therapeutic products. As vital pillars of our CRO (Contract Research Organization) offerings, our Pharmacovigilance & Safety services provide comprehensive oversight from clinical trials to post-marketing surveillance, ensuring regulatory compliance and patient protection. Drawing on global standards like ICH E2, GVP (Good Pharmacovigilance Practices), FDA MedWatch, and NMPA requirements, we empower biopharma sponsors to navigate safety challenges with confidence, turning potential risks into actionable insights for safer therapies.
Why Choose Our Pharmacovigilance & Safety Services?
Our PV services go beyond compliance-they proactively enhance product safety profiles and accelerate market access. With a 24/7 global operations center and expertise in over 50 therapeutic areas, we handle complex safety signals for small molecules, biologics, and medical devices alike.
Key Advantages
Global Expertise Network
A dedicated team of PV specialists, physicians, and epidemiologists with 20+ years of collective experience, managing 200+ active PV programs annually with a 100% on-time reporting rate.
01
Cutting-Edge Technology Suite
AI-enabled signal detection tools, Argus/ARISg safety databases, and automated ICSR (Individual Case Safety Report) workflows reduce processing time by 50% while maintaining ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate) principles.
02
Cost-Effective Scalability
Tailored PV solutions for startups to multinationals, offering up to 30% savings through outsourced models and predictive analytics to prevent adverse event escalations.
03
Proven Risk Management
Integrated safety governance with mock inspections and CAPA (Corrective and Preventive Actions) frameworks, achieving zero regulatory observations in recent EMA audits.
04
Our Pharmacovigilance & Safety Service Modules
We deliver a modular, end-to-end PV ecosystem designed for seamless integration into your clinical or commercial pipeline:
Case Processing & Intake:
○ Global ICSR Management: Rapid triage and data entry from multiple sources (e.g., spontaneous reports, literature, social media), supporting 100+ languages with eVAERS/eMDR integrations.
○ Medical Review: Expert adjudication of causality assessments using WHO-UMC scales, ensuring timely narrative writing and quality checks.
Signal Detection & Risk Management:
○ Proactive Surveillance: Advanced analytics for disproportionality analysis (e.g., PRR, ROR) and cohort event monitoring, identifying emerging signals within 24 hours.
○ RMP (Risk Management Plan) Development: Customized plans with PASS (Post-Authorization Safety Studies) design, including REMS (Risk Evaluation and Mitigation Strategies) for high-risk products.
Regulatory Reporting & Submissions:
○ Automated Compliance: Generation of PSURs (Periodic Safety Update Reports), PBRERs (Periodic Benefit-Risk Evaluation Reports), and expedited E2B(R3) submissions to authorities like FDA, EMA, and NMPA.
○ Aggregate Reporting: Streamlined DSUR (Development Safety Update Reports) for clinical stages, with electronic gateway filings to minimize delays.
Safety Training & Governance:
○ Customized Programs: PV training for sponsor teams and affiliates, covering GVP modules and safety database best practices.
○ Audit & Inspection Readiness: Gap assessments and mock PV audits to fortify your safety systems against regulatory scrutiny.
Post-Marketing & Lifecycle Support:
○ Long-Term Vigilance: Ongoing literature screening, patient registries, and real-world evidence generation to monitor benefit-risk throughout product lifecycle.
Success Story Spotlight
In a Phase III gene therapy trial for a rare neuromuscular disorder, our PV team detected a novel hypersensitivity signal through AI-driven disproportionality screening across 1,500 ICSRs from 15 countries. Swift protocol amendments and enhanced RMP implementation averted a potential trial halt, enabling uninterrupted enrollment and contributing to a landmark EMA conditional approval-safeguarding 200+ patients while expediting therapy access.
Partner with Us to Champion Safety Excellence
Our Pharmacovigilance & Safety services are your vigilant guardian, transforming regulatory obligations into strategic advantages. We are committed to "vigilance, innovation, and partnership," ensuring every safety signal strengthens your pipeline's integrity.
Take the Next Step: Engage our PV experts for a complimentary safety gap analysis or signal detection demo.
The Reliable Accelerator for Pharmaceutical Innovation. Let's secure safer tomorrows-one report at a time!